Related Experiment Video
Updated: Mar 18, 2026

07:23
Bergmeyer Glucose Quantification for Microbiological Samples
Published on: January 17, 2025
1.4K
A simple colorimetric assay for measuring fructosamine 3 kinase activity
Clinical Chemistry and Laboratory Medicine
|July 10, 2016
Summary
A new colorimetric assay quantifies fructosamine 3 kinase (FN3K) activity in serum, aiding diabetes research. This enzyme
Area of Science:
- Biochemistry
- Enzymology
- Clinical Chemistry
Background:
- Fructosamine 3 kinase (FN3K) is a deglycating enzyme with potential to mitigate diabetes-induced organ damage by removing glucose from glycated proteins.
- Developing a straightforward colorimetric method for assaying FN3K activity in human body fluids is crucial for further research.
Purpose of the Study:
- To develop and validate a simple colorimetric assay for measuring fructosamine 3 kinase (FN3K) activity in human serum.
- To establish reference values for FN3K activity in a healthy adult population.
- To investigate the relationship between FN3K activity, diabetes, and specific genetic polymorphisms.
Main Methods:
- Glycated bovine serum albumin (BSA) was prepared and used as a substrate for FN3K.
- Serum samples were incubated with the substrate, MgCl2, and ATP.
- Fructosamine concentration was measured before and after incubation to determine FN3K activity.
- FN3K and ferroportin single nucleotide polymorphisms (SNPs) were genotyped.
Main Results:
- A reliable colorimetric assay for FN3K activity in human serum was established with a within-assay coefficient of variation (CV) of 6.0%.
- Reference values for serum FN3K activity were determined (14.2±1.6 U/L) and found to be independent of age and sex.
- Serum FN3K activity in diabetic patients was comparable to controls, but erythrocyte FN3K activity was significantly higher. A weak but significant correlation was observed between FN3K activity and HbA1c.
- FN3K activity showed dependence on ferroportin Q248H genotypes.
Conclusions:
- A simple colorimetric method for determining FN3K activity in human serum has been successfully developed.
- This assay holds promise for investigating the role of deglycation processes in the context of diabetes mellitus.

